- ongoing, recruitingPhase I and Phase II (Integrated)- Other
A phase I/II trial of D,L-MEthadone and mFOLFOX6 in treatment of advanced colorectal cancer (MEFOX)
This study is testing a new combination of treatments for advanced bowel cancer. It's looking at whether adding a drug called D,L-methadone to standard chemotherapy (mFOLFOX6) can help control the cancer, and how safe it is.
Germany - authorisedTherapeutic confirmatory (Phase III)
A phase III trial of a De-escalated Immune-strategy During first-line treAtment in patients with metastatic non-small Cell lung cancer (NSCLC): DIDaC
This study is for people with advanced lung cancer who have responded well to initial immunotherapy. It's looking at whether using less treatment might still be effective, while potentially reducing side effects. Researchers will track how long participants stay well.
Netherlands